⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL383574 | 0.97 | ADH1A (0.46) | — | |
| Phosphine SCHEMBL27880054 | 0.94 | ADH1A (0.44) | — | |
| SCHEMBL28388990 | 0.94 | ADH1A (0.50) | — | |
| SCHEMBL611858 | 0.94 | ADH1A (0.50) | — | |
| SCHEMBL356022 | 0.94 | ADH1A (0.50) | — | |
| SCHEMBL23073672 | 0.94 | ADH1A (0.50) | — | |
| SCHEMBL613463 | 0.94 | ADH1A (0.50) | — | |
| SCHEMBL612572 | 0.94 | ADH1A (0.50) | — | |
| SCHEMBL150343 | 0.94 | ADH1A (0.50) | — | |
| Fluoride SCHEMBL9620456 | 0.91 | ADH1A (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024025953-A2 | THERAPEUTIC USES OF UROLITHIN DERIVATIVES | VANDRIA SA (CH) | 2024-02-01 | — | — | WO | disclosed |
| US-20210236442-A1 | METHODS FOR DELAYING OCCURRENCE OF NEW-ONSET TYPE 2 DIABETES AND FOR SLOWING PROGRESSION OF AND TREATING TYPE 2 DIABETES | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2021-08-05 | — | — | US | disclosed |
| US-20190070178-A1 | METHODS FOR TREATING OR PREVENTING CARDIOVASCULAR DISORDERS AND LOWERING RISK OF CARDIOVASCULAR EVENTS | DALCOR PHARMA UK LTD., LEATHERHEAD, ZUG BRANCH (CH) | 2019-03-07 | — | — | US | disclosed |
| EP-2076558-B1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | DOW CORNING (US) | 2018-04-18 | — | — | EP | disclosed |
| US-9745321-B2 | Fused pyrimidine compound, intermediate, preparation method therefor, and composition and application thereof | SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) | 2017-08-29 | — | — | US | disclosed |
| EP-2427425-B1 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS INC (US) | 2017-03-08 | — | — | EP | disclosed |
| EP-2125745-B1 | CYCLOALKYLAMINE SUBSTITUTED ISOQUINOLONE DERIVATIVES | SANOFI SA (FR) | 2017-02-22 | — | — | EP | disclosed |
| US-20160214994-A1 | FUSED PYRIMIDINE COMPOUND, INTERMEDIATE, PREPARATION METHOD THEREFOR, AND COMPOSITION AND APPLICATION THEREOF | SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) | 2016-07-28 | — | — | US | disclosed |
| US-9315451-B2 | Tetracycline compounds | TETRAPHASE PHARMACEUTICALS, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| CN-102405224-B | Comprise composition and the Synthesis and applications thereof of season amino-functional silicoorganic compound | EVONIK DEGUSSA GMBH (DE) | 2015-12-16 | — | — | CN | disclosed |
| US-8147789-B2 | Composition comprising neopentasilane and method of preparing same | DOW CORNING CORPORATION (US) | 2012-04-03 | — | — | US | disclosed |
| EP-2421874-A1 | COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF | Evonik Degussa GmbH (DE) | 2012-02-29 | — | — | EP | disclosed |
| US-20120037040-A1 | COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2012-02-16 | — | — | US | disclosed |
| WO-2011062253-A1 | NOVEL FUSED PYRIMIDINE DERIVATIVE | 大日本住友製薬株式会社 (JP) | 2011-05-26 | — | — | WO | disclosed |
| WO-2010129057-A2 | TETRACYCLINE COMPOUNDS | TETRAPHASE PHARMACEUTICALS, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010121873-A1 | COMPOSITION CONTAINING QUATERNARY AMINO-FUNCTIONAL ORGANOSILICON COMPOUNDS AND PRODUCTION AND USE THEREOF | EVONIK DEGUSSA GMBH (DE) | 2010-10-28 | — | — | WO | disclosed |
| US-20100176338-A1 | Composition Comprising Neopentasilane And Method Of Preparing Same | NATA SEMICONDUCTOR MATERIALS CO., LTD. (CN) | 2010-07-15 | — | — | US | disclosed |
| EP-2076558-A1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | Dow Corning Corporation (US) | 2009-07-08 | — | — | EP | disclosed |
| WO-2008051328-A1 | COMPOSITION COMPRISING NEOPENTASILANE AND METHOD OF PREPARING SAME | DOW CORNING CORPORATION (US) | 2008-05-02 | — | — | WO | disclosed |
| US-4390712-A | Aqueous solution of cationic organosilicon compounds and process for the production of the solutions | DEGUSSA AG (DE) | 1983-06-28 | — | — | US | disclosed |